The proinflammatory cytokines released in cancer, such as interleukins IL-1, IL-3, and IL-6, can promote the proliferation of megakaryocytes and increase the presence of large platelets, causing their activation and aggregation and possibly leading to the gradual establishment of thrombocytosis [35]. This evidence concerns the gene IL6 and thrombocytosis disease.